Vascular endothelial growth factor levels in serum and plasma from patients undergoing controlled ovarian hyperstimulation for IVF

Human Reproduction

Volumn 22, Issue 3, 2007, Pages 669-675

  Manau, Dolors ^a   Fábregues, Francisco ^a   Peñarrubia, Joana ^a   Creus, Montserrat ^a   Carmona, Francisco ^a   Casals, Gemma ^a   Jiménez, Wladimiro ^a   Balasch, Juan ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Controlled ovarian hyperstimulation; IVF; Plasma VEGF; Serum VEGF

Indexed keywords

ESTRADIOL; VASCULOTROPIN A;

ADULT; ARTICLE; BLOOD; CHEMISTRY; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; METHODOLOGY; OVULATION INDUCTION; PLASMA; PROSPECTIVE STUDY; SERUM; THROMBOCYTE COUNT;

ADULT; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY, FEMALE; OVULATION INDUCTION; PLASMA; PLATELET COUNT; PROSPECTIVE STUDIES; SERUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34247866508     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/del427     Document Type: Article

References (75)

1. Aboulghar MA, Mansour RT, Serour GI, El Helw BA and Shaarawy M (1999) Elevated levels of interleukin-2, soluble interleukin-2 receptor alpha, interleukin-6, soluble interleukin-6 receptors and vascular endothelial growth factor in serum and ascitic fluid of patients with severe ovarian hyperstimulation syndrome. Eur J Obstet Gynecol Reprod Biol 87,81-85.
2. Abramov Y, Barak V, Nisman B and Schenker JG (1997) Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertil Steril 67,261-265.
3. Adams J, Carder PJ, Downey S, Forbes MA, MacLennan K, Allgar V, Kaufman S, Hallam S, Bicknell R, Wlker JJ, Cairnduff F, Selby PJ, Perren TJ, Lansdown M and Banks RE (2000) Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen. Cancer Res 60,2898-2905.
4. Agrawal R, Conway G, Sladkevicius P, Tan SL, Engmann L, Payne N, Bekir J, Campbell S and Jacobs H (1998) Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries. Fertil Steril 70,651-658.
5. Agrawal R, Tan SL, Wild S, Sladkevicius P, Engmann L, Payne N, Bekir J, Campbell S, Conway G and Jacobs H (1999) Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predicts the risk of ovarian hyperstimulation syndrome. Fertil Steril 71,287-293.
6. Agrawal R, Jacobs H, Payne N and Conway G (2002) Concentration of vascular endothelial growth factor released by cultured human luteinized granulosa cells is higher in women with polycystic ovaries than in women with normal ovaries. Fertil Steril 78,1164-1169.
7. Artini PG, Monti M, Fasciani A, Tartaglia ML, D'Ambrogio G and Genazzani AR (1998a) Correlation between the amount of follicle-stimulating hormone administered and plasma and follicular fluid vascular endothelial growth factor concentrations in women undergoing in vitro fertilization. Gynecol Endocrinol 12,243-247.
8. Artini PG, Fasciani A, Monti M, Luisi S, D'Ambrogio G and Genazzani AR (1998b) Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in an in vitro fertilization program. Fertil Steril 70,560-564.
9. Artini PG, Monti M, Fasciani A, Battaglia C, D'Ambrogio G and Genazzani AR (2002) Vascular endothelial growth factor, interleukin-6 and interleukin-2 in serum and follicular fluid of patients with ovarian hyperstimulation syndrome. Eur J Obstet Gynecol Reprod Biol 101,169-174.
10. Asimakopoulos B, Nikolettos N, Papachristou DN, Simopoulou M, Al-Hasani S and Diedrich K (2005) Follicular fluid levels of vascular endothelial growth factor and leptin are associated with pregnancy outcome of normal women participating in intracytoplasmic sperm injection cycles. Physiol Res 54,263-270.
11. Babayof R, Margalioth EJ, Huleihel M, Amash A, Zylber-Haran E, Gal M, Brooks B, Mimoni T and Eldar-Geva T (2006) Serum inhibin A, VEGF and TNF alpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial. Hum Reprod 21,1260-1265.
12. Balasch J, Guimerá M, Martinez-Pasarell O, Ros J, Vanrell JA and Jiménez W (2004) Adrenomedullin and vascular endothelial growth factor production by follicular fluid macrophages and granulosa cells. Hum Reprod 19,808-814.
13. Banks RE, Forbes MA, Kinsey SE, Stanley A, Ingham E, Walters C and Selby PJ (1998) Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer 77,956-964.
14. Battaglia C, Genazzani AD, Regnani G, Primavera MR, Petraglia F and Volpe A (2000) Perifollicular Doppler flow and follicular fluid vascular endothelial growth factor concentrations in poor responders. Fertil Steril 74,809-812.
15. Bussen S and Dietl J (2003) Progonostic value of VEGF levels for ovarian hyperstimulation. Fertil Steril 80,681-682.
16. Cavender JL and Murdoch WJ (1988) Morphological studies of the microcirculatory system of periovulatory ovine follicles. Biol Reprod 39,989-997.
17. Chen C, Wu Chen H, Chen S, Ho H and Yang Y (2000a) Relationships of serum pro-inflammatory cytokines and vascular endothelial growth factor with liver dysfunction in severe ovarian hyperstimulation syndrome. Hum Reprod 15,66-71.
18. Chen C, Chen H, Lu H, Chen S, Ho H and Yang Y (2000b) Value of serum and follicular fluid cytokine profile in the prediction of moderate to severe ovarian hyperstimulation syndrome. Hum Reprod 15,1037-1042.
19. Christenson LK and Stouffer RL (1997) Follicle-stimulating hormone and luteinizing hormone/chorionic gonadotropin stimulation of vascular endothelial growth factor production by macaque granulosa cells from preand periovulatory follicles. J Clin Endocrinol Metab 82,2135-2142.
20. D'Ambrogio G, Fasciani A, Monti M, Cattani R, Genazzani AR and Arini PG (1999) Serum vascular endothelial growth factor levels before starting gonadotropin treatment in women who have developed moderate forms of ovarian hyperstimulation syndrome. Gynecol Endocrinol 13,311-315.
21. Dorn C, Reinsberg J, Kupka M, van der Ven H and Schild RL (2003) Leptin, VEGF, IGF-1, and IGFBP-3 concentrations in serum and follicular fluid of women undergoing in vitro fertilization. Arch Gynecol Obstet 268,187-193.
22. 165) are not elevated during gonadotropin stimulation in in vitro fertilization (IVF) patients developing ovarian hyperstimulation syndrome (OHSS): results of a prospective cohort study matched controls. Eur J Obstet Gynecol Reprod Biol 96,196-201.
23. Ferrara N (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25,581-611.
24. Ferrara N and Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18,4-25.
25. Ferrero S (2004) Serum and plasma vascular endothelial growth factor levels in testicular cancer patients. Ann Oncol 15,989-990.
26. Ferrero S, Gillott DJ, Anserini P, Remorgida V, Teisner B and Grudzinskas JG (2004) Methodological concerns regarding levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis. Hum Reprod 19,220-221.
27. Gagné D, Pagé M, Robitaille G, Hugo P and Gosselin D (2003) Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis. Hum Reprod 18,1674-1680.
28. García-Velasco JA and Pellicer A (2003) New concepts in the understanding of the ovarian hyperstimulation syndrome. Curr Opin Obstet Gynecol 15,251-256.
29. García-Velasco JA, Zuñiga A, Pacheco A, Gómez R, Simón C, Remohí J and Pellicer A (2004) Coasting acts through downregulation of VEGF gene expression and protein secretion. Hum Reprod 19,1530-1538.
30. George ML, Eccles SA, Tutton MG, Abulafi AM and Swift RI (2000) Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? Clin Cancer Res 6,3147-3152.
31. Geva E and Jaffe RB (2000) Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril 74,429-438.
32. Geva E, Amit A, Lessing JB, Lerner-Geva L, Daniel Y, Yovel I, Azem F and Barak V (1999) Follicular fluid levels of ovarian endothelial growth factor. Are they predictive markers of ovarian hyperstimulation syndrome? J Reprod Med 44,91-96.
33. Griesinger G, Dafopoulos K, Schultze-Mosgau A, Jelkmann W, von Otte S, Diesing D and Diedrich K (2006) Vascular endothelial growth factor response to exogenous chorionic gonadotropic hormone in the luteal phase of women with a history of severe ovarian hyperstimulation syndrome. Arch Gynecol Obstet 274,29-33.
34. Gunsilius E and Gastl G (1999) Platelets and VEGF blood levels in cancer patients. Br J Cancer 81,184-186.
35. Hormbrey E, Gillespie P, Turner K, Han C, Roberts A, McGrouther D and Harris AL (2002) A critical review of vascular endothelial growth factor (VEGF) analysis in peripheral blood: Is the current literature meaningful? Clin Exp Metastasis 19,651-663.
36. Jelkmann W (2001) Pitfalls in the measurement of circulating vascular endothelial growth factor. Clin Chem 47,617-623.
37. Krasnow JS, Berga SL, Guzick DS, Zeleznik AJ and Yeo KT (1996) Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report. Fertil Steril 65,552-555.
38. Kusumanto YH, Dam WA, Hospers GAP, Meijer C and Mulder NH (2003) Platelets and granulocytes, in particular the neutrophils, from important compartments for circulating vascular endothelial growth factor. Angiogenesis 6,283-287.
39. Larsson A, Sköldenberg E and Ericson H (2002) Serum and plasma levels of FGF-2 and VEGF in healthy blood donors. Angiogenesis 5,107-110.
40. Lebovic DI, Mueller MD and Taylor RN (1999) Vascular endothelial growth factor in reproductive biology. Curr Opin Obstet Gynecol 11,255-260.
41. Lee A, Christenson LK, Stouffer RL, Burry KA and Patton PE (1997) Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization. Fertil Steril 68,305-311.
42. Lee JK, Hong YJ, Han CJ, Hwang DY and Hong SI (2000) Clinical usefulness of serum and plasma vascular endothelial growth factor in cancer patients: which is the optimal specimen? Int J Oncol 17,149-152.
43. Licht P, Neuwinger J, Fischer O, Siebzehnrübl E and Wildt L (2002) VEGF plasma pattern in ovulation induction: evidence for an episodic secretion and lack of immediate effect of hCG. Exp Clin Endocrinol Diabetes 110,130-133.
44. Ludwig M, Bauer O, Loens A, Jelkmann W and Diedrich K (1998) Serum concentrations of vascular endothelial growth factor cannot predict the course of severe ovarian hyperstimulation syndrome. Hum Reprod 13,30-32.
45. Ludwig M, Jelkmann W, Bauer O and Diedrich K (1999) Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration. Hum Reprod 14,2437-2441.
46. Manau D, Balasch J, Jiménez W, Fábregues F, Cívico S, Casamitjana R, Creus M and Vanrell JA (2000) Follicular fluid concentrations of adrenomedullin, vascular endothelial growth factor and nitric oxide in IVF cycles: relationship to ovarian response. Hum Reprod 15,1295-1299.
47. Manau D, Arroyo V, Jiménez W, Fábregues F, Vanrell JA and Balasch J (2002) Chronology of hemodynamic changes in asymptomatic in vitro fertilization patients and relationship with ovarian steroids and cytokines. Fertil Steril 77,1178-1183.
48. Matalliotakis IM, Goumenou AG, Koumantakis GE, Neonaki MA, Koumantakis EE, Dionyssopoulou E, Athanassakis I and Vassiliadis S (2003) Serum concentrations of growth factors in women with and without endometriosis: the action of anti-endometriosis medicines. Int Immunopharmacol 3,81-89.
49. Mathur R, Hayman G, Bansal A and Jenkins J (2002) Serum vascular endothelial growth factor levels are poorly predictive of subsequent ovarian hyperstimulation syndrome in highly responsive women undergoing assisted conception. Fertil Steril 78,1154-1158.
50. McElhinney B, Ardill J, Caldwell C, Lloyd F and McClure N (2002a) Ovarian hyperstimulation syndrome and assisted reproductive technologies: why some and not others? Hum Reprod 17,1548-1553.
51. McElhinney B, Ardill J, Caldwell C, Lloyd F and McClure N (2002b) Variations in serum vascular endothelial growth factor binding profiles and the development of ovarian hyperstimulation syndrome. Fertil Steril 78,286-290.
52. McIIhenny C, George WD and Doughty JC (2002) A comparison of serum and plasma levels of vascular endothelial growth factor during the menstrual cycle in healthy female volunteers. Br J Cancer 86,1786-1789.
53. Molskness TA, Stouffer RL, Burry KA, Gorrill MJ, Lee DM and Patton PE (2004) Circulating levels of free and total vascular endothelial growth factor (VEGF) -A, soluble VEGF receptors-1 and -2, and angiogenin during ovarian stimulation in non-human primates and women. Hum Reprod 19,822-830.
54. Moncayo HF, Penz-Koza A, Marth C, Gastl G, Herold M and Moncayo R (1998) Vascular endothelial growth factor in serum and in the follicular fluid of patients undergoing hormonal stimulation for in-vitro fertilization. Hum Reprod 13,3310-3314.
55. Neeman M, Abramovitch R, Schiffenbauer YS and Tempel C (1997) Regulation of angiogenesis by hypoxic stress: from solid tumours to the ovarian follicle. Int J Exp Path 78,57-70.
56. Neulen J, Raczek S, Pogorzelski M, Grunwald K, Yeo TK, Dvorak HF, Weich HA and Breckwoldt M (1998) Secretion of vascular endothelial growth factor/vascular permeability factor from human luteinized granulosa cells is human chorionic gonadotrophin dependent. Mol Hum Reprod 4,203-206.
57. Ocal P, Aydin S, Cepni I, Idil S, Idil M, Uzun H and Benian A (2004) Follicular fluid concentrations of vascular endothelial growth factor, inhibin A and inhibin B in IVF cycles: are they markers for ovarian response and pregnancy outcome? Eur J Obstet Gynecol Reprod Biol 115,194-199.
58. Ogawa S, Minakami H, Araki S, Ohno T, Motoyama M, Shibahara H and Sato I (2001) A rise of the serum level of von Willebrand factor occurs before clinical manifestation of the severe form of ovarian hyperstimulation syndrome. J Assist Reprod Genet 6,114-119.
59. Ohta M, Konno H, Tanaka T, Baba M, Kamiya K, Syouji T, Kondoh K, Watanabe M, Terada H and Nakamura S (2003) The significance of circulating vascular endothelial growth factor (VEGF) protein in gastric cancer. Cancer Lett 192,215-225.
60. Okuda Y, Okamura H, Kanzaki H and Takenaka A (1983) Capillary permeability of rabbit ovarian follicles prior to ovulation. J Anat 137,263-269.
61. Oliveira VA, Abreu LG, Ferriani RA, Reis RM and Moura MD (2005) Vascular endothelial growth factor in the plasma, follicular fluid and granulosa cells of women with endometriosis submitted to in vitro fertilization - a pilot study. Gynecol Endocrinol 20,284-288.
62. Pau E, Alonso-Muriel I, Gomez R, Novella E, Ruiz A, Garcia-Velasco JA, Simón C and Pellicer A (2006) Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome. Hum Reprod [February 17, Epub ahead of print].
63. Pellicer A, Albert C, Mercader A, Bonilla-Musoles F, Remohí J and Simón C (1998) The follicular and endocrine environment in women with endometriosis: local and systemic cytokine production. Fertil Steril 70,425-431.
64. Pellicer A, Albert C, Mercader A, Bonilla-Musoles F, Remohí J and Simón C (1999a) The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor. Fertil Steril 71,482-489.
65. Pellicer A, Garrido N, Albert C, Navarro J, Remohí J and Simón C (1999b) Cytokines in older patients undergoing in vitro fertilization: the relationship to the response to controlled ovarian hyperstimulation. J Assist Reprod Genet 16,247-252.
66. Salgado R, Vermeulen PB and Van Marck Benoy I (2001) Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? Clin Cancer Res 7,1481-1482.
67. Salven P, Orpana A and Joensuu H (1999) Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor. Clin Cancer Res 5,487-491.
68. Spence GM, Graham AN, Mulholland K, McAllister I, Sloan JM, Armstrong MA, Campbell FC and McGuigan JA (2002) Vascular endothelial growth factor levels in serum and plasma following esophageal cancer resection - relationship to platelet count. Int J Biol Markers 17,119-124.
69. Tanaka N, Espey LL and Okamura H (1989) Increase in ovarian blood volume during ovulation in the gonadotropin-primed immature rat. Biol Reprod 40,762-768.
70. Tokuyama O, Nakamura Y, Muso A, Fujino Y, Ishiko O and Ogita S (2002) Vascular endothelial growth factor concentrations in follicular fluid obtained from IVF-ET patients: a comparison of hMG, clomiphene citrate, and natural cycle. J Assist Reprod Genet 19,19-23.
71. Tozer AJ, Iles RK, Iammarrone E, Gillott CM, Al-Shawaf T and Grudzinskas JG (2004) The effects of 'coasting' on follicular fluid concentrations of vascular endothelial growth factor in women at risk of developing ovarian hyperstimulation syndrome. Hum Reprod 19,522-528.
72. Unkila-Kallio L, Vuorela-Vepsäläinen P, Titinen A, Halmesmäki E and Ylikorkala O (2000) No cyclicity in serum vascular endothelial growth factor during normal menstrual cycle but significant luteal phase elevation druing an in vitro fertilization program. Am J Reprod Immunol 43,25-30.
73. Wang T, Horng S, Chang C, Wu H, Tsai Y, Wang H and Soong Y (2002) Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor. J Clin Endocrinol Metab 87,3300-3308.
74. Webb NJA, Bottomley MJ, Watson CJ and Brenchley PEC (1998) Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin Sci 94,395-404.
75. Zackrisson U, Mikuni M, Peterson MC, Nilsson B, Janson PO and Brännström M (2000) Evidence for the involvement of blood flow-related mechanisms in the ovulatory process of the rat. Hum Reprod 15,264-272.